Overview
Severe mitral valve regurgitation (MR) is characterized by significant backflow of blood from the left ventricle into the left atrium, often leading to hemodynamic instability and multi-organ dysfunction 1.Diagnosis
Clinical Presentation: Symptoms include dyspnea, fatigue, and signs of heart failure such as pulmonary edema.
Echocardiography: Essential for grading severity (typically ≥4+ on a 0-4+ scale) and assessing leaflet function 1.
Cardiac Catheterization: May be used to confirm hemodynamic findings and assess left ventricular function 1.Management
First-Line Treatments:
- Medical Therapy: Diuretics, vasodilators (e.g., ACE inhibitors, ARBs), and inotropes to manage symptoms and stabilize hemodynamics 1.
Adjunctive Treatments:
- Mechanical Support: ECMO and intra-aortic balloon pump for severe hemodynamic instability 1.
- Interventional Procedures: MitraClip for patients unsuitable for surgery due to multi-organ failure 1.Special Populations
Multi-Organ Failure: Interventional approaches like MitraClip can be effective in critically ill patients with multi-organ failure where surgery is contraindicated 1.Key Recommendations
Consider MitraClip for Severe MR in Patients with Inoperable Multi-Organ Failure: Interventional valve reconstruction can stabilize hemodynamics and reverse organ dysfunction (Evidence: Weak) 1.
Utilize ECMO and Mechanical Support in Hemodynamically Unstable Patients: These devices can bridge the gap to definitive therapy or recovery (Evidence: Weak) 1.
Prioritize Surgical Repair When Feasible: Surgical intervention remains the gold standard for severe MR when patient condition permits (Evidence: Expert opinion) 1.References
1 Staudacher DL, Bode C, Wengenmayer T. Severe mitral regurgitation requiring ECMO therapy treated by interventional valve reconstruction using the MitraClip. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2015. link